調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022

次世代シーケンシング（NGS）の世界市場予測（～2022）

◆タイトル：Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022
◆商品コード：MAM-BT2697
◆調査・発行会社：MarketsandMarkets
◆発行日：2017年4月4日
◆ページ数：217
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ技術
◆販売価格オプション（消費税別）
Single User（1名利用）USD5,650 ⇒換算￥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥896,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、次世代シーケンシング（NGS）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品種類別分析、サービス別分析、用途別分析、地域別分析、次世代シーケンシング（NGS）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The next-generation sequencing market is expected to reach USD 12.45 Billion by 2022 from USD 4.90 Billion in 2017, at a CAGR of 20.5% between 2017 and 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market. In addition, storage of sequencing data and interpretation of complex data from NGS platforms are major concerns faced by the sequencing industry.
This report broadly segments the global NGS market into products & services, technology, application, and end user. On the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market.

On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina’s systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.

Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing & developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases.

On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. For instance, in November 2016, Illumina, Inc. entered into an agreement with Mayo Clinic (U.S.) to install its BaseSpace Clarity LIMS in Mayo’s specific laboratories.

This report covers the NGS market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, due to the improving healthcare infrastructure and favorable government initiatives in this region.

The major players in the global market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N. V. (Germany), Pacific Biosciences of California, Inc. (U.S.), BGI (China), Oxford Nanopore Technologies, Ltd. (U.K.), PerkinElmer, Inc. (U.S.), GATC Biotech AG (Germany), Agilent Technologies, Inc. (U.S.), Roche Holding AG (Switzerland), Macrogen, Inc. (South Korea), and Eurofins Scientific (Luxembourg).

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Research Methodology Steps
2.2 Research Design
2.3 Secondary and Primary Research Methodology
2.3.1 Secondary Research
2.3.1.1 Key Data From Secondary Sources
2.3.2 Primary Data
2.3.2.1 Breakdown of Primaries
2.3.2.2 Key Data From Primary Sources
2.3.2.3 Key Industry Insights
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 32)
3.1 Introduction

4 Premium Insights (Page No. – 36)
4.1 Next-Generation Sequencing (NGS): Market Overview
4.2 NGS Market, By Product & Service (2017 vs 2022)
4.3 NGS Market Size, By Application, 2017 vs 2022
4.4 NGS Market, By End User (2017 vs 2022)
4.5 Geographic Analysis: NGS Market Size, By Product & Service (2017 vs 2022), USD Million

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Technological Advancements in Sequencing Platforms
5.2.1.2 Increasing Applications of NGS
5.2.1.3 Growing Number of Partnerships and Collaborations
5.2.1.4 Increasing Adoption of NGS Technologies Among Research Laboratories and Academic Institutes
5.2.1.5 Conferences and Workshops Increasing Awareness on NGS Products and Services
5.2.2 Restraints
5.2.2.1 Dearth of Skilled Professionals
5.2.2.2 Difficulties in Storage of Sequencing Data
5.2.3 Opportunities
5.2.3.1 Government Initiatives in Population Sequencing
5.2.3.2 Application of NGS in Precision Medicine & Biomarker Discovery
5.2.3.3 Emerging Markets Offer Significant Growth Opportunities
5.2.3.4 Cloud Computing, A Prospective Service
5.2.4 Challenges
5.2.4.1 Interpretation of Complex Data From NGS Platforms
5.2.4.2 Accuracy & Standardization Concerns in Diagnostic Testing
5.2.4.3 Issues Related to the Security of NGS Data
5.2.5 Industry Trends
5.2.5.1 Integration of Next-Generation Sequencing With Cloud-Based Technology
5.2.5.2 Focus on Cancer Research
5.2.5.3 Mergers and Acquisitions
5.2.5.4 Entry of New Market Players

6 Next-Generation Sequencing Market, By Product & Service (Page No. – 53)
6.1 Introduction
6.2 Pre-Sequencing Products & Services Market
6.2.1 Sample Preparation
6.2.1.1 Dna Fragmentation, End Repair, A-Tailing, and Size Selection
6.2.1.2 Library Preparation & Target Enrichment
6.2.1.3 Quality Control
6.3 NGS Platforms, Consumables, & Services for Platforms
6.3.1 NGS Platforms Market
6.3.1.1 Illumina
6.3.1.1.1 Hiseq Series
6.3.1.1.2 Hiseq X Ten & Hiseq X Five
6.3.1.1.3 Miseq Series
6.3.1.1.4 Nextseq 500
6.3.1.1.5 Miniseq
6.3.1.2 Thermo Fisher Scientific (Life Technologies)
6.3.1.2.1 ION PGM
6.3.1.2.2 ION Proton
6.3.1.2.3 ION S5 & S5 XL
6.3.1.3 Pacific Biosciences
6.3.1.3.1 Pacbio Rs II
6.3.1.3.2 Sequel System
6.3.1.4 Oxford Nanopore
6.3.1.5 Other Next-Generation Sequencing Platforms
6.3.1.6 Recently Launched Sequencing Platforms
6.4 Sequencing Services Market
6.4.1 Targeted Re-Sequencing
6.4.2 Rna-Seq
6.4.3 De Novo Sequencing
6.4.4 Exome Sequencing
6.4.5 Chip-Seq
6.4.6 Whole-Genome Sequencing
6.4.7 Methyl-Seq
6.4.8 Other Applications
6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
6.5.1 NGS Data Analysis Software & Workbenches
6.5.2 NGS Data Analysis Services
6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Next-Generation Sequencing Market, By Technology (Page No. – 83)
7.1 Introduction
7.2 Sequencing By Synthesis
7.3 ION Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing

8 Next-Generation Sequencing Market, By Application (Page No. – 90)
8.1 Introduction
8.2 Diagnostics
8.3 Drug Discovery
8.4 Biomarker Discovery
8.5 Precision Medicine
8.6 Agriculture & Animal Research
8.7 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. – 101)
9.1 Introduction
9.2 Research Centers and Academic & Government Institutes
9.3 Hospitals & Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users

10 Next-Generation Sequencing Market, By Region (Page No. – 107)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Favorable Government Funding Scenario in the U.S. Market
10.2.1.2 Growing Focus of NGS Market Players on Strengthening Their Presence in the U.S.
10.2.1.3 Increasing Number of NGS Conferences in the U.S.
10.2.2 Canada
10.2.2.1 Favorable Government Funding Scenario in Canada
10.2.2.2 Growing Focus of Market Players on Expanding Their Presence in Canada
10.3 Europe
10.3.1 Market Players Capitalizing on Opportunities in the European NGS Market
10.3.1.1 Launch of New and Advanced Products and Services
10.3.1.2 Partnerships/Agreements/Collaborations
10.3.2 Germany, U.K., and Belgium: Major Hubs for Scientific Research
10.3.3 Growing Funding and Investments for NGS in Europe
10.4 Asia-Pacific
10.4.1 Growing Focus of Domestic and Multinational Players on APAC Market
10.4.1.1 Launch of Advanced NGS Products and Services
10.4.1.2 Partnerships/Collaborations/Agreements to Co-Develop Advanced NGS Products and Services
10.4.2 Favorable Government Funding Scenario
10.4.3 Conferences/Seminars/Training Programs
10.5 Rest of the World (RoW)
10.5.1 Focus of Key Market Players on Expanding Their Presence in RoW Countries
10.5.2 Workshops and Conferences
10.5.3 Favorable Initiatives By Public and Private Organizations

11 Competitive Landscape (Page No. – 136)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches, Product Enhancements, and Service Launches
11.3.2 Agreements, Partnerships, Collaborations, and Contracts
11.3.3 Mergers and Acquisitions
11.3.4 Expansions
11.3.5 Other Developments

12 Company Profiles (Page No. – 144)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.1.1 Geographic Benchmarking
12.2 Illumina, Inc.
12.3 Thermo Fisher Scientific Inc.
12.4 Pacific Biosciences of California, Inc.
12.5 Qiagen N.V.
12.6 Beijing Genomics Institute
12.7 Perkinelmer, Inc.
12.8 F. Hoffmann-La Roche AG
12.9 Agilent Technologies, Inc.
12.10 Gatc Biotech AG
12.11 Oxford Nanopore Technologies, Ltd.
12.12 Macrogen, Inc.
12.13 Eurofins Scientific

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 206)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables (96 Tables)

Table 1 List of Sequencing Platforms Launched By Market Players During 2015–2017
Table 2 New Market Players and Their Sequencing Platforms
Table 3 NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 4 Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 5 Pre-Sequencing Products & Services Market Size, By Region, 2015–2022 (USD Million)
Table 6 Dna Fragmentation, End Repair, A-Tailing, & Size Selection Market Size, By Region, 2015–2022 (USD Million)
Table 7 Library Preparation & Target Enrichment Market Size, By Region, 2015–2022 (USD Million)
Table 8 Quality Control Market Size, By Region, 2015–2022 (USD Million)
Table 9 NGS Instruments, Consumables, and Services Market Size, By Type, 2015–2022 (USD Million)
Table 10 NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 11 NGS Consumables Market Size, By Region, 2015–2022 (USD Million)
Table 12 NGS Services for NGS Systems Market Size, By Region, 2015–2022 (USD Million)
Table 13 Illumina NGS Platforms Market Size, By Product, 2015–2022 (USD Million)
Table 14 Illumina NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 15 Hiseq Series Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 16 Hiseq X Ten & Hiseq X Five Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 17 Miseq Series Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 18 Nextseq 500 Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 19 Miniseq Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 20 Thermo Fisher Scientific NGS Platforms Market Size, By Product, 2015–2022 (USD Million)
Table 21 Thermo Fisher Scientific NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 22 ION PGM Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 23 ION Proton Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 24 ION S5 & S5 XL Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 25 Pacific Biosciences NGS Platforms Market Size, By Product, 2015–2022 (USD Million)
Table 26 Pacific Biosciences NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 27 Pacbio Rs II Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 28 Sequel System Market Size, By Region, 2015–2022 (USD Million)
Table 29 Oxford Nanopore NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 30 Other NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 31 Sequencing Services Market Size, By Application, 2015–2022 (USD Million)
Table 32 Sequencing Services Market Size, By Region, 2015–2022 (USD Million)
Table 33 NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 34 NGS Bioinformatics Market Size, By Region, 2015–2022 (USD Million)
Table 35 Data Analysis Software and Workbenches Market Size, By Region, 2015–2022 (USD Million)
Table 36 Data Analysis Services Market Size, By Region, 2015–2022 (USD Million)
Table 37 Next-Generation Sequencing Technologies, By Company
Table 38 Global Next-Generation Sequencing Market Size, By Technology, 2015–2022 (USD Million)
Table 39 Sequencing By Synthesis Market Size, By Region, 2015–2022 (USD Million)
Table 40 ION Semiconductor Sequencing Market Size, By Region, 2015–2022 (USD Million)
Table 41 Single-Molecule Real-Time Sequencing Market Size, By Region, 2015–2022 (USD Million)
Table 42 Nanopore Sequencing Market Size, By Region, 2015–2022 (USD Million)
Table 43 Next-Generation Sequencing Market Size, By Application, 2015–2022 (USD Million)
Table 44 Next-Generation Sequencing Market Size for Diagnostics, By Region, 2015–2022 (USD Million)
Table 45 Next-Generation Sequencing Market Size for Drug Discovery, By Region, 2015–2022 (USD Million)
Table 46 Next-Generation Sequencing Market Size for Biomarker Discovery, By Region, 2015–2022 (USD Million)
Table 47 Next-Generation Sequencing Market Size for Precision Medicine, By Region, 2015–2022 (USD Million)
Table 48 Next-Generation Sequencing Market Size for Agriculture and Animal Research, By Region, 2015–2022 (USD Million)
Table 49 Next-Generation Sequencing Market Size for Other Applications, By Region, 2015–2022 (USD Million)
Table 50 Next-Generation Sequencing Market Size, By End User, 2015–2022 (USD Million)
Table 51 Next-Generation Sequencing Market Size for Research Centers and Academic & Government Institutes, By Region, 2015–2022 (USD Million)
Table 52 Next-Generation Sequencing Market Size for Hospitals & Clinics, By Region, 2015–2022 (USD Million)
Table 53 Next-Generation Sequencing Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 54 Next-Generation Sequencing Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 55 NGS Market Size, By Region, 2015–2022 (USD Million)
Table 56 North America: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 57 North America: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 58 North America: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 59 North America: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 60 North America: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 61 North America: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 62 North America: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 63 North America: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 64 North America: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 65 Europe: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 66 Europe: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 67 Europe: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 68 Europe: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 69 Europe: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 70 Europe: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 71 Europe: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 72 Europe: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 73 Europe: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 74 Asia-Pacific: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 75 Asia-Pacific: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 76 Asia-Pacific: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 77 Asia-Pacific: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 78 Asia-Pacific: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 79 Asia-Pacific: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 80 Asia-Pacific: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 81 Asia-Pacific: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 82 Asia-Pacific: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 83 RoW: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 84 RoW: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 85 RoW: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 86 RoW: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 87 RoW: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 88 RoW: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 89 RoW: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 90 RoW: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 91 RoW: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 92 Top 5 Product Launches, Product Enhancements, and Service Launches 2016–2017 (January)
Table 93 Top 5 Agreements, Partnerships, Collaborations, and Contracts 2016–2017 (January)
Table 94 Top 5 Mergers and Acquisitions, 2015–2017 (January)
Table 95 Top Geographic Expansions, 2016
Table 96 Top 5 Other Developments, 2015–2017 (January)

List of Figures (35 Figures)

Figure 1 Global Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 NGS Market: Bottom-Up Approach
Figure 4 NGS Market: Top-Down Approach
Figure 5 NGS Market: Data Triangulation
Figure 6 Global NGS Market, By Application, 2017 vs 2022 (USD Million)
Figure 7 Global NGS Platforms Market, 2017 vs 2022
Figure 8 Global NGS Market, By End User, 2017 vs 2022 (USD Million)
Figure 9 Global NGS Market, By Region, 2016 (USD Million)
Figure 10 NGS Market to Register A High, Double-Digit Growth Rate in the Forecast Period (2017–2022)
Figure 11 Pre-Sequencing Products & Services Segment to Register the Highest CAGR Between 2017 & 2022
Figure 12 Diagnostics Application Will Continue to Dominate the NGS Market in 2022
Figure 13 Research Centers and Academic & Government Institutes to Account for the Largest Share of the NGS Market in 2017
Figure 14 Consumables Will Be the Dominant Product Segment in All Regions
Figure 15 NGS Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Nanopore Sequencing to Register the Highest CAGR During 2017 to 2022
Figure 17 Diagnostics Application Segment Will Continue to Dominate the Global Next-Generation Sequencing Market in 2022 (USD Million)
Figure 18 Hospitals & Clinics to Register the Highest CAGR in the Forecast Period
Figure 19 Global NGS Market Overview
Figure 20 North America: NGS Market Snapshot
Figure 21 Europe: NGS Market Snapshot
Figure 22 Asia-Pacific: NGS Market Snapshot
Figure 23 RoW: NGS Market Snapshot
Figure 24 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Three Years (2014 to January, 2017)
Figure 25 Global NGS Platform Market Share Analysis, By Key Player, 2016
Figure 26 Geographic Revenue Mix of the Top Four Market Players* (2016)
Figure 27 Illumina, Inc.: Company Snapshot (2016)
Figure 28 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 29 Pacific Biosciences of California, Inc.: Company Snapshot (2015)
Figure 30 Qiagen N.V.: Company Snapshot (2016)
Figure 31 Perkinelmer, Inc.: Company Snapshot (2015)
Figure 32 Roche Holding AG: Company Snapshot (2016)
Figure 33 Agilent Technologies, Inc.: Company Snapshot (2016)
Figure 34 Macrogen, Inc.: Company Snapshot (2015)
Figure 35 Eurofins Scientific: Company Snapshot (2016)

【レポートのキーワード】

次世代シーケンシング（NGS）、次世代シーケンサー、次世代シーケンシング製品、次世代シーケンシングサービス

★調査レポート[次世代シーケンシング（NGS）の世界市場予測（～2022）] ( Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022 / MAM-BT2697) 販売に関する免責事項
[次世代シーケンシング（NGS）の世界市場予測（～2022）] ( Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022 / MAM-BT2697) についてEメールでお問い合わせ
◆関連調査資料◆
  • 次世代シークエンシング（NGS）の世界市場予測（～2021）
  • 臓器移植検査の世界市場：血清学的検査、混合リンパ球培養試験（MLC）、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）
  • 血液検査の世界市場：技術（核酸増幅検査（NAT）、ELISA法、EIA法、CLIA法、次世代シーケンシング、ウエスタンブロット法）、試薬、装置
  • 癌・腫瘍プロファイリングの世界市場予測（～2021）：用途別、手法別（ゲノミクス、 プロテオミクス、メタボロミクス、エピジェネティックス）、技術別（次世代シーケンシング、qPCR、in-situハイブリダイゼーション、マイクロアレイ）
  • バイオインフォマティクス（生命情報学）の世界市場予測：分子医学、農業、法医学、動物、研究、遺伝子治療
  • サービスとしてのアクセスコントロール（ACaaS）の世界市場予測（～2022）：サービス別、導入別、最終用途別（商用、製造＆産業、政府機関、公共設備）、地域別
  • 渦電流探傷試験（ECT）の世界市場予測（～2022）
  • ワイヤレス・コネクティビティ（無線通信）の世界市場予測（～2022）
  • 試験/検査/認証（TIC）の世界市場予測（～2022）
  • 電磁弁（ソレノイドバルブ）の世界市場予測（～2022）

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆